Tongling Jieya Biologic Technology Balance Sheet Health
Financial Health criteria checks 6/6
Tongling Jieya Biologic Technology has a total shareholder equity of CN¥1.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.1B and CN¥279.3M respectively. Tongling Jieya Biologic Technology's EBIT is CN¥42.4M making its interest coverage ratio -1.9. It has cash and short-term investments of CN¥1.3B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.9x |
| Cash | CN¥1.30b |
| Equity | CN¥1.85b |
| Total liabilities | CN¥279.29m |
| Total assets | CN¥2.13b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301108's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥238.2M).
Long Term Liabilities: 301108's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥41.1M).
Debt to Equity History and Analysis
Debt Level: 301108 is debt free.
Reducing Debt: 301108 has no debt compared to 5 years ago when its debt to equity ratio was 1.5%.
Debt Coverage: 301108 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301108 has no debt, therefore coverage of interest payments is not a concern.